# A Safety and Efficacy Study of Different Injections Volumes of Botulinum Toxin Type A, Azzalure, in the Glabellar Lines

> **NCT02108158** · PHASE4 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 62 (actual)

## Conditions studied

- Glabellar Frown Lines

## Interventions

- **DRUG:** Azzalure

## Key facts

- **NCT ID:** NCT02108158
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2022-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02108158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02108158, "A Safety and Efficacy Study of Different Injections Volumes of Botulinum Toxin Type A, Azzalure, in the Glabellar Lines". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02108158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*